The Wasdell Group invests in Serialisation

The Wasdell Group invests £2.6 million in Serialisation EU regulations (EU Directive 2011/62/EU on falsified medicines) require that from February 2019 there be a unique 2D Datamatrix code and human readable data on every saleable unit of drug product intended for release to a patient. In line with these regulations the Wasdell Group will provide […]

Read more

Wasdell Group Makes Move into Manufacturing

The Wasdell Group have added Contract Manufacturing to their range of services to the pharmaceutical industry. Wasdell Manufacturing Ltd operates from a 26,000 ft2 site in Newcastle upon Tyne and further strengthens Wasdell’s position in the market adding manufacturing capability to their established expertise in packaging, engineering and logistics. Daniel Tedham has been appointed as […]

Read more